Spots Global Cancer Trial Database for secondary amyloidosis
Every month we try and update this database with for secondary amyloidosis cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Copper 64Cu-DOTA-Daratumumab Positron Emission Tomography in Diagnosing Patients With Relapsed Multiple Myeloma | NCT03311828 | Recurrent Plasm... Plasma Cell Mye... Secondary Amylo... | Daratumumab Imaging Agent Positron Emissi... Pharmacological... | 18 Years - | City of Hope Medical Center | |
Copper 64Cu-DOTA-Daratumumab Positron Emission Tomography in Diagnosing Patients With Relapsed Multiple Myeloma | NCT03311828 | Recurrent Plasm... Plasma Cell Mye... Secondary Amylo... | Daratumumab Imaging Agent Positron Emissi... Pharmacological... | 18 Years - | City of Hope Medical Center |